Preziosa, P., Rocca, M. A., Markozannes, G., Pantzaris, M. C., Valsasina, P., Grigoriadis, N., . . . Patrikios, I. (2022). Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: The MINERAL Study. BMJ Publishing Group.
Чикаго стиль цитування (17-те видання)Preziosa, Paolo, et al. Phase III, Randomised, Double-blind, Placebo-controlled Trial of Neuroaspis Plp10 as an Adjuvant Treatment for Relapsing Multiple Sclerosis: The MINERAL Study. BMJ Publishing Group, 2022.
Стиль цитування MLA (9-ме видання)Preziosa, Paolo, et al. Phase III, Randomised, Double-blind, Placebo-controlled Trial of Neuroaspis Plp10 as an Adjuvant Treatment for Relapsing Multiple Sclerosis: The MINERAL Study. BMJ Publishing Group, 2022.